Chromatin-modifying enzymes as therapeutic targets – Part 1

By Keppler Brian R   Archer Trevor K  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1301-1312

Informa Healthcare

Access to resources Recommend Favorite

Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-03 ,pp. : 788-806

Bentham Science Publishers

Access to resources Recommend Favorite

Methods for synthesis and uses of inhibitors of Ghrelin O-acyltransferase inhibitors as potential therapeutic agents for obesity and diabetes

By Costantino Luca  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1603-1607

Informa Healthcare

Access to resources Recommend Favorite

Dexibuprofen: pharmacology, therapeutic uses and safety

By Kaehler S. T.  

Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. : 371-383

VSP

Access to resources Recommend Favorite

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

By  

Current Medicinal Chemistry, Vol. 21, Iss. 36, 2014-12 ,pp. : 4100-4131

Bentham Science Publishers

Access to resources Recommend Favorite